FOXO Technologies Inc. (FOXO) company profile
Close on Oct 19, 2026Market cap –P/E –Yield –
About FOXO Technologies
Services-Commercial Physical & Biological Research, SIC 8731
FOXO Technologies Inc. engages in activities spanning the healthcare, biotechnology, and behavioral health sectors through its subsidiaries and business agreements. The company’s operations involve behavioral health services, medical equipment, and software development, in addition to epigenetic applications and methylation data pipelines. Its commercial activities include structured service arrangements and acquisitions involving partners such as Myrtle Recovery Centers, Rennova Community Health, and Vector Acquisition to serve individuals requiring behavioral health and related medical care.
The provided filing text consists largely of accounting schedules and XBRL disclosure elements referencing transactions related to Tennessee's Hospital Improvement Plan and associated medical entities. The excerpt does not state specific scale metrics—such as total store or clinic counts—nor does it identify the company's operating countries or headquarters location.
Summary of the business section of FOXO Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- FOXO Technologies Inc.
- Headquarters
- West Palm Beach, FL
- Address
- 477 South Rosemary Avenue, Suite 224 33401
- Phone
- (612) 800-0059
- Website
- foxotechnologies.com
- Employees
- 192, Dec 31, 2025
- Industry
- Services-Commercial Physical & Biological Research
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Kreit & Chiu CPA LLP, Los Angeles, California
Stock & identifiers
- Ticker
- FOXO
- Other tickers
- FOXOW
- Former tickers
- DWIN until Sep 16, 2022
- Exchange
- OTC
- IPO date
- Dec 11, 2020
- Shares outstanding
- 2M, Aug 11, 2026
- Public float
- $1.86M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-3000 reverse, Jul 1, 2026; 1-for-10 reverse, Apr 29, 2025; 1-for-10 reverse, Nov 7, 2023
- SEC CIK
- 1812360
- FIGI
- BBG00XP21MK3
- Share class FIGI
- BBG00XP21ML2
- EIN
- 85-1050265
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
FOXO Technologies's leadership is listed in its proxy statement (Form DEF 14A).
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Dec 11, 2020
- Offer price
- $10.00
- Securities offered
- 17,500,000
- Gross proceeds
- $175.00M
- Exchange
- NYSE
- First trading day
- Sep 19, 2022
- First-day close
- $2.50-75.0%
- Lock-up ends (est.)
- Mar 18, 2023
“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one -half of one redeemable warrant.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“of March 10, 2026 we had 192 employees, of which 117 were full-time.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?